Yinghong Wang
M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Yinghong Wang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:16 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06807593 · Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer PatientsM.D. Anderson Cancer Center · recruiting · Cancer · principal investigator
- Ph1/Ph2NCT04407247 · Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or MelanomaM.D. Anderson Cancer Center · active not recruiting · Colitis, Lung Non-Small Cell Carcinoma, Malignant Genitourinary System Neoplasm · principal investigator
- Ph1NCT04038619 · Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer PatientsM.D. Anderson Cancer Center · recruiting · Colitis, Diarrhea, Malignant Genitourinary System Neoplasm · principal investigator
- Ph1NCT03819296 · Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerM.D. Anderson Cancer Center · recruiting · Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8 · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:16 UTC. The ranking covers the 200 most relevant of 6879 PubMed records, and a shared surname and initials can bring in a namesake. All 6879 on PubMed
- Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.Nat Med · 202628 citationsRCR 14.0
- 27 citationsRCR 13.5
- 19 citationsRCR 9.5
- Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial.J Clin Oncol · 202616 citationsRCR 8.0
- 14 citationsRCR 7.0
- Effect of a Computer-Aided Device for Detecting Gastric Neoplasms: A Multicenter, Randomized Controlled Trial.Gastroenterology · 202614 citationsRCR 7.0
- Electrical impedance tomography-guided positive end-expiratory pressure and mortality of patients with the acute respiratory distress syndrome: the EITVent randomized clinical trial.Am J Respir Crit Care Med · 202612 citationsRCR 6.0
- Effect of esketamine on postoperative depression and anxiety in patients undergoing cardiac valve surgery: A randomised, placebo-controlled, double-blinded clinical trial.Pharmacol Res · 202510 citationsRCR 5.3
- 9 citationsRCR 4.5
- 8 citationsRCR 4.0